Community/Retail

SpartanNash associates collectively volunteered 20,234 hours in 2016, exceeding the company’s goal of 15,000 volunteer hours by 35%.

The appearance of Zika virus in the United States has accelerated the search for a vaccine.

If you could go back in time and mentor yourself, what would you say?

Pharmacists can play an important role in preventing foodborne illness.

Heat failure (HF) caused 1 in 9 deaths in the United States in 2009.

Eight individuals from Texas have been charged for their participation in a health care fraud scheme involving at least 3 pharmacies and $158 million in false claims for costly compound medications, according to the Department of Justice (DOJ).

The FDA has approved Dupixent (dupilumab) injection, from Sanofi and Regeneron Pharmaceuticals, for the treatment of adults with inadequately controlled moderate-to-severe atopic dermatitis (AD).

Consumers feeling overloaded by DTC pharmaceutical ads.

Thanks for following us on Twitter, Instagram, and Facebook!

The Kroger Co. has launched its new website at www.krogerstories.com.

The Allergy & Asthma Network and Avella Specialty Pharmacy have released a new white paper to underscore the significant risks related to latex allergies and the use of latex in healthcare.

The FDA has approved Tesaro’s Zejula (niraparib) for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.

“From research to health care: Your pharmacist is at your service” is the theme of this year’s World Pharmacists Day on 25 September, the International Pharmaceutical Federation (FIP) announced today.

In this clip taken at APhA 2017, Evan Sisson, PharmD, of VCU School of Pharmacy discusses the role of the pharmacist in counseling patients about cardiovascular medication and nutraceutical use.

Adults who receive vaccination reimbursement through an employer-sponsored pharmacy insurance benefit may be more likely to receive vaccinations, according to data revealed in a poster presentation at the American Pharmacists Association (APhA) 2017 Annual Meeting & Exposition in San Francisco.

A recent study has examined the accuracy of the US Preventive Services Task Force (USPSTF) and American College of Cardiology/American Heart Association (ACC/AHA) recommendations for identifying African American individuals who would benefit from statins.

Advocacy, patient feedback encouraged during APhA keynote address.

Public perceptions on naloxone may differ by community.

At the American Pharmacists Association 2017 meeting, an inspiring and practical session titled “Leading by Example” showed how pharmacists can leverage their value to establish health care team partnerships (eg, with health systems and physician practices) and implement programs to win pharmacy “champions,” improve patient outcomes, and reduce health care costs.

Pharmacists play an important role in helping to deal with clinical inertia.

There are several new options coming down the pipeline for patients with type 2 diabetes.

Continuing education remains an important part of a pharmacist's life, particularly those dealing with an ever-increasing population of patients with diabetes.

There are several new treatments in the pipeline that hold promise for patients with type 2 diabetes.

Sessions focuses on new diabetes treatment options.

Two new fixed-dose basal/GLP-1 receptor-agonist agents, Soliqua 100/33 (Sanofi) and Xultophy 100/3.6 (Novo Nordisk), were approved by the FDA in November 2016.

In this clip, Jeffrey Fudin, PharmD, who spoke at APHA 2017 on opioid tapering, discusses options pharmacists should consider when tapering patients.

Failing to secure sufficient support for their proposed Affordable Care Act (ACA) replacement, Republicans leaders have pulled the American Health Care Act (AHCA) from the House floor, cancelling a scheduled vote on the health care legislation

In this clip, Jeffrey Fudin, PharmD, discusses available options in abuse-deterrent formulations of opioids.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.